There has been significant progress throughout 2014 in cardiothoracic and vascular anaesthesia and intensive care. There has been a revolution in the clinical approach to acute and chronic adult aortic diseases. Contemporary management of adult aortic disease is based on etiology, clinical presentation, extent, and integrated intervention with medical, endovascular and/or surgical measures. Further European guidelines have explored in depth the cardiovascular management in non-cardiac surgery with a thematic focus to reduce perioperative mortality from the leading offender, namely myocardial ischemia. Integrated guidelines address the management of myocardial revascularization including the percutaneous and surgical options. Despite 50 years since the first coronary artery bypass grafting procedure and impressive advances in interventional cardiology, surgical revascularization remains a gold standard for many patients with coronary artery disease. These advances in 2014 will likely further improve perioperative outcomes for our patients.

• Klíčová slova
• European Association of Cardiothoracic Surgery, European Society of Anaesthesiology, European Society of Cardiology, aorta, aspirin, beta-blockers, clonidine, coronary artery bypass grafting, fenoldopam, guidelines, intra-aortic balloon pump, myocardial ischemia, myocardial revascularization, non-cardiac surgery, percutaneous coronary intervention, statins, troponin, volatile anesthetics,
• Publikační typ
• časopisecké články MeSH